TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

LEADING

NeurologyCardiovascularGastroenterology
Generics

LEADING is a generic drug manufacturer focused on Neurology, Cardiovascular, Gastroenterology.

2005
Since
17
Drugs
-
Trials
154
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

KETOROLAC TROMETHAMINE 2026-01-22
Labeling
OSELTAMIVIR PHOSPHATE 2026-01-22
OSELTAMIVIR PHOSPHATE 2026-01-15
Labeling
FUROSEMIDE 2026-01-08
LORAZEPAM 2026-01-05
Labeling
LEUCOVORIN CALCIUM 2025-11-12
OSELTAMIVIR PHOSPHATE 2025-10-02
Manufacturing (CMC)
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE 2025-09-19
Manufacturing (CMC)
FUROSEMIDE 2025-09-12
Labeling
FUROSEMIDE 2025-09-08
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Neurology 38%
2 drugs
Cardiovascular 19%
1 drugs
Gastroenterology 19%
1 drugs
Oncology 19%
1 drugs
Dermatology 6%
0 drugs Phase 1: 2

Pipeline Strength Pro

Loading...

Competitors Pro

Pfizer big-pharma
Oncology, Dermatology, Gastroenterology
Baxter specialty
Cardiovascular, Oncology, Dermatology
Eli Lilly big-pharma
Oncology, Neurology, Dermatology
Bayer big-pharma
Oncology, Cardiovascular, Dermatology
Bristol-Myers Squibb big-pharma
Oncology, Gastroenterology, Neurology